ArticleeNeurologicalSci2023

Successful treatment with subcutaneous ofatumumab in an adolescent patient with refractory myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD).

Satomi Hiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.